ARCHIVES

Managed Care Limits Access To Trials, Cancer Panel Says

This article is from The Cancer Letter archive.

Vol. 21 No. 32 | August 11, 1995

Download PDF Visit The Full Archive

Related Articles

In Brief: Terms Expire Next Year For Six NCAB Members, One On Panel; Fraumeni Preventative Oncology President

October 16, 1981

Natural Product Drug Discovery Groups Receive Concept Approval

February 26, 1988

Evidence “Weak” Linking EMFs, cancer

June 25, 1999

Amgen Agrees To Buy Immunex For $16 Billion In Stock And Cash.

January 25, 2002

NCI Cooperative Group Clinical Trials Approved

January 29, 2010

Mozobil Plus G-CSF Increases Rate Of Cell Mobilization

September 30, 2005